Intellia Therapeutics Inc...
(NTLA)
undefined
undefined%
At close: undefined
12.94
0.35%
After-hours Dec 13, 2024, 07:22 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Revenue | 36.27M | 52.12M | 33.05M | 57.99M | 43.10M | 30.43M | 26.12M | 16.48M | 6.04M | - |
Cost of Revenue | 8.98M | 7.57M | 6.89M | 150.41M | 108.41M | 89.11M | 67.65M | 31.84M | 11.17M | 1.66M |
Gross Profit | 27.30M | 44.55M | 26.16M | -92.41M | -65.31M | -58.68M | -41.53M | -15.36M | -5.13M | -1.66M |
Operating Income | -515.29M | -458.16M | -267.85M | -136.58M | -106.37M | -90.87M | -69.56M | -32.16M | -13.41M | -5.23M |
Interest Income | 49.83M | 8.54M | 1.28M | 2.35M | 6.83M | 5.53M | 2.01M | 525.00K | - | - |
Pretax Income | -481.19M | -474.19M | -267.89M | -134.23M | -99.53M | -85.34M | -67.54M | -31.63M | -13.41M | -14.31M |
Net Income | -481.19M | -490.21M | -259.72M | -125.57M | -92.70M | -85.34M | -67.54M | -31.63M | -12.40M | -14.31M |
Selling & General & Admin | 116.50M | 90.31M | 71.10M | 44.17M | 41.06M | 32.19M | 28.02M | 16.80M | 8.28M | 3.57M |
Research & Development | 435.07M | 419.98M | 229.81M | 150.41M | 108.41M | 89.11M | 67.65M | 31.84M | 11.17M | 10.74M |
Other Expenses | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | 551.57M | 510.29M | 300.90M | 194.58M | 149.47M | 121.30M | 95.67M | 48.64M | 19.45M | 12.65M |
Interest Expense | - | 8.54M | - | - | - | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 551.57M | 510.29M | 300.90M | 194.58M | 149.47M | 121.30M | 95.67M | 48.64M | 19.45M | 14.31M |
Income Tax | - | 16.02M | -8.17M | -8.66M | -6.83M | 5.53M | -2.99M | -1.10M | -1.01M | - |
Shares Outstanding (Basic) | 88.77M | 76.97M | 70.89M | 55.99M | 47.25M | 43.07M | 36.01M | 22.22M | 17.66M | 485.88K |
Shares Outstanding (Diluted) | 88.77M | 76.97M | 70.89M | 55.99M | 47.25M | 43.07M | 36.01M | 22.22M | 17.66M | 485.88K |
EPS (Basic) | -5.42 | -6.37 | -3.66 | -2.24 | -1.96 | -1.98 | -1.88 | -1.42 | -0.7 | -29.45 |
EPS (Diluted) | -5.42 | -6.37 | -3.66 | -2.24 | -1.96 | -1.98 | -1.88 | -1.42 | -0.7 | -29.45 |
EBITDA | -506.31M | -450.59M | -260.96M | -130.27M | -100.78M | -86.41M | -66.56M | -31.05M | -13.08M | -9.54M |
Depreciation & Amortization | 8.98M | 7.57M | 6.89M | 6.31M | 5.59M | 4.46M | 2.99M | 1.10M | 328.00K | 4.50K |